Join to view full profile
1 Gustave L Levy PlFl 12New York, NY 10029
Phone+1 212-987-7208
Fax+1 212-731-5220
Dr. Campbell is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Kirk Campbell, MD, is a nephrologist based in Philadelphia, with a rich educational background from UConn School of Medicine, Yale-New Haven Medical Center, and Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital. He boasts ample experience in managing glomerular diseases, dialysis, and hereditary kidney diseases. Dr. Campbell is a published author in several reputable journals in his field, and has been involved in clinical trials
Education & Training
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Nephrology, 2004 - 2007
Yale-New Haven Medical CenterResidency, Internal Medicine, 2000 - 2003
Uconn School Of MedicineClass of 2000
Certifications & Licensure
NY State Medical License 2004 - 2027
PA State Medical License 2025 - 2026
FL State Medical License 2008 - 2012
CT State Medical License 2003 - 2004
American Board of Internal Medicine Nephrology
Clinical Trials
- Optimal Dosing of IC-Green for Visualization of Rotator Cuff Vascularity Using Advanced Imaging Modality Arthroscopy Start of enrollment: 2021 Jan 27
Publications & Presentations
PubMed
- Targeting B cells in immune-mediated kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.Jürgen Floege, Isabelle Ayoub, Silke R Brix, Kirk N Campbell, Richard Furie
Kidney International. 2026-09-01 - Percutaneous Native Kidney Biopsy Complications in Diabetic Patients in the TRIDENT Cohort.Samer Mohandes, Mohammad Fakhreddine, Henry Sheng, Mohammed Al Dulaimee, Amy Mottl
Clinical Journal of the American Society of Nephrology. 2026-08-01 - Podocyte-Targeted Therapy in Focal Segmental Glomerulosclerosis: Insights From a Phase 2 Trial of TRPC6 Inhibition.Luis Sanchez-Russo, George Vasquez-Rios, Kirk N Campbell
American Journal of Kidney Diseases. 2026-07-01
Journal Articles
- Autophagy Is a Gatekeeper of Hepatic Differentiation and Carcinogenesis by Controlling the Degradation of YapKirk N Campbell, Mark J Czaja, M Isabel Fiel, Kemal M Akat, Scott L Friedman, Nature
- DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGSHoward Trachtman, Peter Nelson, Abanti Chaudhuri, Jai Radhakrishnan, Olga Zhdanova, Debbie S Gipson, Tarak Srivastava, Kenneth Lieberman, Vimal Kumar Derebail, Jonatha..., Journal of the American Society of Nephrology
Press Mentions
NKF Spring Clinical Meetings 2026 to Tout Actionable ResearchApril 29th, 2026- Dinushika Mohottige, MD, Named NKF's Medical Advisory Board Distinguished Service Award WinnerApril 1st, 2025
- New York City Surgeon Presented with the Excellence in Kidney Transplantation AwardMarch 21st, 2025
Grant Support
- Plasminogen in glomerular disease progressionICAHN SCHOOL OF MEDICINE AT MOUNT SINAI2020–2030
- Hippo-YAP in podocyte health and diseaseUNIVERSITY OF PENNSYLVANIA2025–2029
- Hippo-YAP in podocyte health and diseaseUNIVERSITY OF PENNSYLVANIA2025–2029
- Postbaccalaureate Research Education Program (PREP)ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI2001–2029
- New York Consortium for Interdisciplinary Training in Kidney, Urological and Hematological Research (NYC Train KUHR)ALBERT EINSTEIN COLLEGE OF MEDICINE2022–2027
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
